{"id":"W2174423882","doi":"10.1007/s10549-015-3643-5","title":"Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis","year":2015,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Hazard ratio; Metastatic breast cancer; Oncology; Breast cancer; Progression-free survival; Randomized controlled trial; Clinical trial; Meta-analysis; Cancer; Overall survival; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.006205037,0.002200264,0.008922909,0.001132662,0.000364239,0.001754191,0.001572983,0.001561009,0.003594589],"category_scores_gemma":[0.01298653,0.001075036,0.03014025,0.002290663,0.0004276779,0.001185234,0.001084446,0.002750144,0.000381928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00105404,"about_ca_system_score_gemma":0.0009756609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00394742,"about_ca_topic_score_gemma":0.0110597,"domain_scores_codex":[0.9959744,0.002186419,0.0007715274,0.0006197491,0.0002832324,0.0001647269],"domain_scores_gemma":[0.9941532,0.004120308,0.0008310925,0.0004288483,0.0003285018,0.0001379558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00782719,0.00003562629,0.01043545,0.03391537,0.9369609,0.00007167797,0.00004136275,0.0007169667,0.0002849235,0.0001186401,0.0006446995,0.008947168],"study_design_scores_gemma":[0.001067591,0.0002432799,0.005434515,0.001077483,0.9905369,0.00004776798,0.00002143204,0.0002486296,0.00007466033,0.0002674247,0.0009637277,0.00001667541],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.03426558,0.9611027,0.001926666,0.000337819,0.0003999232,0.0001314693,0.001146793,0.00006549657,0.0006236797],"genre_scores_gemma":[0.7106184,0.2799935,0.003358718,0.001576898,0.0005292788,0.0003622997,0.002040615,0.00009529004,0.001425005],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9910771,"threshold_uncertainty_score":0.03281575,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3655082059876479,"score_gpt":0.5081216217604009,"score_spread":0.142613415772753,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}